Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans

Pelham Barton

doi:10.1093/rheumatology/ker244

Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans

Pelham Barton

Research output: Contribution to journal › Review article

9 Citations (Scopus)

Abstract

The Birmingham Rheumatoid Arthritis Model (BRAM) has been developed over a number of years to inform several appraisals of biologic drugs by the Technology Appraisals Committee of the UK National Institute for Health and Clinical Excellence. This article describes the processes used in the construction of the different versions of the BRAM.

Original language	English
Pages (from-to)	iv32-iv38
Journal	Rheumatology
Volume	50
DOIs	https://doi.org/10.1093/rheumatology/ker244
Publication status	Published - 1 Sept 2011

Keywords

Cost-effectiveness analysis
Rheumatoid arthritis
Biologic therapies
NICE
Modelling

Access to Document

10.1093/rheumatology/ker244

Cite this

@article{f47bad8426bf49ddb80cd0267b9f8253,

title = "Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans",

abstract = "The Birmingham Rheumatoid Arthritis Model (BRAM) has been developed over a number of years to inform several appraisals of biologic drugs by the Technology Appraisals Committee of the UK National Institute for Health and Clinical Excellence. This article describes the processes used in the construction of the different versions of the BRAM.",

keywords = "Cost-effectiveness analysis, Rheumatoid arthritis, Biologic therapies, NICE, Modelling",

author = "Pelham Barton",

year = "2011",

month = sep,

day = "1",

doi = "10.1093/rheumatology/ker244",

language = "English",

volume = "50",

pages = "iv32--iv38",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans

AU - Barton, Pelham

PY - 2011/9/1

Y1 - 2011/9/1

N2 - The Birmingham Rheumatoid Arthritis Model (BRAM) has been developed over a number of years to inform several appraisals of biologic drugs by the Technology Appraisals Committee of the UK National Institute for Health and Clinical Excellence. This article describes the processes used in the construction of the different versions of the BRAM.

AB - The Birmingham Rheumatoid Arthritis Model (BRAM) has been developed over a number of years to inform several appraisals of biologic drugs by the Technology Appraisals Committee of the UK National Institute for Health and Clinical Excellence. This article describes the processes used in the construction of the different versions of the BRAM.

KW - Cost-effectiveness analysis

KW - Rheumatoid arthritis

KW - Biologic therapies

KW - NICE

KW - Modelling

U2 - 10.1093/rheumatology/ker244

DO - 10.1093/rheumatology/ker244

M3 - Review article

C2 - 21859704

SN - 1462-0324

VL - 50

SP - iv32-iv38

JO - Rheumatology

JF - Rheumatology

ER -

Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans

Abstract

Keywords

Access to Document

Fingerprint

Cite this